logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Fulltext. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital : Value of the infectious diseases specialist.

    Article - En anglais

    Fulltext.

    Controlling antimicrobial costs has preoccupied infectious diseases physicians (IDPs).

    IDPs have controlled antimicrobial costs by the use of eight strategies : education, formulary restriction, pharmacy justification, formulary substitution, computer surveillance, laboratory item cost listing, purchase plans, and multidisciplinary approaches.

    Most strategies had input from IDPs and resulted in cost savings (up to $500,000 annually), particularly during the initiation periods.

    Educational efforts were successful in reducing costs but needed continual intervention.

    Formulary restriction was the most straightforward cost-control mechanism.

    Restriction of « target antimicrobials » has given way to « switch » therapy between expensive and less costly agents or between parenteral and oral regimens.

    Switch therapy is facilitated through the use of innovative order forms and on-line computer interaction.

    Computer surveillance has a capacity for interactive controls.

    Purchase plans may give way to centralized pharmacy monitoring, a strategy that is attractive to managed care organizations.

    Multidisciplinary antimicrobial management programs (AMPs) offer the best potential for sustaining savings in antimicrobial costs.

    Ten recommendations lay a groundwork for IDPs to translate their expertise into leadership of AMPs.

    Mots-clés Pascal : Infection, Coût, Aspect économique, Traitement, Education, Médecin, Antimicrobien, Hôpital, Economie santé

    Mots-clés Pascal anglais : Infection, Costs, Economic aspect, Treatment, Education, Physician, Antimicrobial agent, Hospital, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0239669

    Code Inist : 002B05A02. Création : 11/06/1997.